These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11395902)

  • 1. Update on drug sieving coefficients and dosing adjustments during continuous renal replacement therapies.
    Golper TA
    Contrib Nephrol; 2001; (132):349-53. PubMed ID: 11395902
    [No Abstract]   [Full Text] [Related]  

  • 2. Determinants of drug removal by continuous hemofiltration.
    Lau AH; Kronfol NO
    Int J Artif Organs; 1994 Jul; 17(7):373-8. PubMed ID: 7806423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and drug dosing adjustments during continuous venovenous hemofiltration or hemodiafiltration in critically ill patients.
    Bugge JF
    Acta Anaesthesiol Scand; 2001 Sep; 45(8):929-34. PubMed ID: 11576041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug dosing during continuous arteriovenous hemofiltration.
    Bickley SK
    Clin Pharm; 1988 Mar; 7(3):198-206. PubMed ID: 3281789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dosage adjustment of drugs during continuous hemofiltration. Results and practical consequences of a prospective clinical study].
    Kroh U; Hofmann W; Dehne M; el Abed K; Lennartz H
    Anaesthesist; 1989 May; 38(5):225-32. PubMed ID: 2660626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug administration in critically ill patients with acute renal failure.
    Kroh UF
    New Horiz; 1995 Nov; 3(4):748-59. PubMed ID: 8574606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug removal during continuous arteriovenous hemofiltration: theory and clinical observations.
    Golper TA; Wedel SK; Kaplan AA; Saad AM; Donta ST; Paganini EP
    Int J Artif Organs; 1985 Nov; 8(6):307-12. PubMed ID: 4077288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding renal replacement therapy and dosing of drugs in pediatric patients with kidney disease.
    Zuppa AF
    J Clin Pharmacol; 2012 Jan; 52(1 Suppl):134S-40S. PubMed ID: 22232749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug removal in continuous haemofiltration and haemodialysis.
    Davies JG; Kingswood JC; Sharpstone P; Street MK
    Br J Hosp Med; 1995 Nov 15-Dec 12; 54(10):524-8. PubMed ID: 8574497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of continuous renal replacement therapy on drug therapy.
    Susla GM
    Clin Pharmacol Ther; 2009 Nov; 86(5):562-5. PubMed ID: 19727069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination of flucytosine by continuous hemofiltration.
    Lau AH; Kronfol NO
    Am J Nephrol; 1995; 15(4):327-31. PubMed ID: 7573192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug dosing adjustments during continuous renal replacement therapies.
    Golper TA; Marx MA
    Kidney Int Suppl; 1998 May; 66():S165-8. PubMed ID: 9573596
    [No Abstract]   [Full Text] [Related]  

  • 13. The pharmacokinetics and extracorporeal removal of N-acetylcysteine during renal replacement therapies.
    Hernandez SH; Howland M; Schiano TD; Hoffman RS
    Clin Toxicol (Phila); 2015; 53(10):941-9. PubMed ID: 26484583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of pharmacokinetic studies in critically ill patients receiving continuous renal replacement therapy.
    Vaara S; Pettila V; Kaukonen KM
    Acta Anaesthesiol Scand; 2012 Feb; 56(2):147-57. PubMed ID: 22092254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Principles of antibacterial dosing in continuous renal replacement therapy.
    Choi G; Gomersall CD; Tian Q; Joynt GM; Freebairn R; Lipman J
    Crit Care Med; 2009 Jul; 37(7):2268-82. PubMed ID: 19487930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Elimination of drugs by hemofiltration. Principles and literature data].
    Hilt H; Keller F
    Anasth Intensivther Notfallmed; 1987 Dec; 22(6):278-82. PubMed ID: 3326424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of using modification of diet in renal disease versus Cockcroft-Gault equations for renal dosing adjustments.
    Moranville MP; Jennings HR
    Am J Health Syst Pharm; 2009 Jan; 66(2):154-61. PubMed ID: 19139480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of continuous renal replacement therapy.
    Schetz M; Ferdinande P; Van den Berghe G; Verwaest C; Lauwers P
    Intensive Care Med; 1995 Jul; 21(7):612-20. PubMed ID: 7593908
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro clearance of trace elements via continuous renal replacement therapy.
    Nakamura AT; Btaiche IF; Pasko DA; Jain JC; Mueller BA
    J Ren Nutr; 2004 Oct; 14(4):214-9. PubMed ID: 15483781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of meropenem in intensive care unit patients receiving continuous veno-venous hemofiltration or hemodiafiltration.
    Giles LJ; Jennings AC; Thomson AH; Creed G; Beale RJ; McLuckie A
    Crit Care Med; 2000 Mar; 28(3):632-7. PubMed ID: 10752806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.